Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RASCIN: Aggressive vs Conservative Blood Glucose Control in Hospitalized Type 2 Diabetes
NCT00906529Phase 4Withdrawn
- Sponsor
- UT Southwestern Medical Center
- Start
- May 2009
- Primary completion
- Dec 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin detemir, insulin aspart in type 2 diabetes mellitus (T2DM), sponsored by UT Southwestern Medical Center. Planned start May 2009; status: withdrawn.
02
Drugs
insulin detemirinsulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00906529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00906529.